Cargando…

Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy

Chronic hepatitis B virus (HBV) infection is a major global health burden affecting around 257 million people worldwide. The consequences of chronic HBV infection include progressive liver damage, liver cirrhosis, and hepatocellular carcinoma. Although current direct antiviral therapies successfully...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heim, Kathrin, Neumann-Haefelin, Christoph, Thimme, Robert, Hofmann, Maike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763562/ https://www.ncbi.nlm.nih.gov/pubmed/31620140 http://dx.doi.org/10.3389/fimmu.2019.02240

Ejemplares similares

TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection
por: Heim, Kathrin, et al.
Publicado: (2021)

TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation
por: Wieland, Dominik, et al.
Publicado: (2017)

HBV-Specific CD8+ T-Cell Tolerance in the Liver
por: Baudi, Ian, et al.
Publicado: (2021)

SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
por: Reeg, David B., et al.
Publicado: (2023)

Immune escape pathways from the HBV core(18-27) CD8 T cell response are driven by individual HLA class I alleles
por: Walker, Andreas, et al.
Publicado: (2022)

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma
por: Tauber, Catrin, et al.
Publicado: (2019)

Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection
por: Oberhardt, Valerie, et al.
Publicado: (2022)

The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation
por: Esser-Nobis, Katharina, et al.
Publicado: (2016)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
por: Ferrando-Martinez, Sara, et al.
Publicado: (2021)

ERAP1 allotypes shape the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection
por: Kemming, Janine, et al.
Publicado: (2019)

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
por: Wild, Katharina, et al.
Publicado: (2021)

Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression
por: Zhu, Zhiqiang, et al.
Publicado: (2022)

Tetramer Enrichment Reveals the Presence of Phenotypically Diverse Hepatitis C Virus-Specific CD8(+) T Cells in Chronic Infection
por: Nitschke, Katja, et al.
Publicado: (2014)

Liver-resident CD8(+) T cells in viral hepatitis: not always good guys
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
por: Boettler, Tobias, et al.
Publicado: (2022)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Prospects for NK-based immunotherapy of chronic HBV infection
por: Jin, Xiaomeng, et al.
Publicado: (2022)

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

Chronische Hepatitis-B-Virusinfektion: aktuelle und zukünftige Therapieansätze
por: Neumann-Haefelin, Christoph, et al.
Publicado: (2022)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia
por: Bajwa, Gagan, et al.
Publicado: (2022)

Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8(+) T‐cell responses in hepatocellular carcinoma
por: Flecken, Tobias, et al.
Publicado: (2014)

Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8(+) T cells
por: Winkler, Frances, et al.
Publicado: (2023)

CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
por: Smith, Corinne J., et al.
Publicado: (2016)

Erratum: Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia
Publicado: (2023)

Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2015)

COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation
por: Reinscheid, Matthias, et al.
Publicado: (2022)

The Role of Natural Killer Cells and CD8(+) T Cells in Hepatitis B Virus Infection
por: Schuch, Anita, et al.
Publicado: (2014)

IFNα subtype-specific susceptibility of HBV in the course of chronic infection
por: Xie, Xiaohong, et al.
Publicado: (2022)

Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8(+) Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
por: Taylor, Alison, et al.
Publicado: (2017)

Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy
por: Zoldan, Katharina, et al.
Publicado: (2021)

Decreased granzyme-B expression in CD11c(+)CD8(+) T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma
por: Gao, Lin, et al.
Publicado: (2023)

Methodologies for the Analysis of HCV-Specific CD4(+) T Cells
por: Lokhande, Megha U., et al.
Publicado: (2015)

Adaptive Immune Response against Hepatitis C Virus
por: Kemming, Janine, et al.
Publicado: (2020)

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
por: Zhang, Junfeng, et al.
Publicado: (2023)

Divide and Conquer: Phenotypic and Temporal Heterogeneity Within CD8(+) T Cell Responses
por: Richard, Arianne C.
Publicado: (2022)

Rapid Antigen Processing and Presentation of a Protective and Immunodominant HLA-B*27-restricted Hepatitis C Virus-specific CD8(+) T-cell Epitope
por: Schmidt, Julia, et al.
Publicado: (2012)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
por: Durgeau, Aurélie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r32luqgvqnd4qf7210158pkpf9